KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash & Current Investments (2016 - 2025)

Biogen (BIIB) has 17 years of Cash & Current Investments data on record, last reported at $97.6 million in Q3 2025.

  • For Q3 2025, Cash & Current Investments fell 94.26% year-over-year to $97.6 million; the TTM value through Jun 2025 reached $2.8 billion, up 44.52%, while the annual FY2024 figure was $2.4 billion, 126.21% up from the prior year.
  • Cash & Current Investments reached $97.6 million in Q3 2025 per BIIB's latest filing, down from $2.8 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $6.1 billion in Q2 2023 and bottomed at $97.6 million in Q3 2025.
  • Average Cash & Current Investments over 5 years is $3.0 billion, with a median of $2.8 billion recorded in 2025.
  • The widest YoY moves for Cash & Current Investments: up 141.84% in 2025, down 94.26% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $3.8 billion in 2021, then increased by 28.67% to $4.9 billion in 2022, then plummeted by 78.54% to $1.0 billion in 2023, then skyrocketed by 126.21% to $2.4 billion in 2024, then plummeted by 95.89% to $97.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $97.6 million in Q3 2025, $2.8 billion in Q2 2025, and $2.6 billion in Q1 2025.